Back to Podcast

IA en salud en Latinoamérica: Dr. Luis Eduardo Pino (Oxer) con Arkangel AI

Arkangel AI & Oxer on AI in Latin America: clinical validation, training, system integration

by Jose Zea•3 min read

AI in Latin American Healthcare: Arkangel AI & Oxer Lead Transformation

This episode dives into artificial intelligence in health, highlighting real-world advancements from Arkangel AI and Oxer, a leading clinical startup. Gain unique perspectives—from military roots to oncology practice—on AI integration in Latin America's health sector.

How Deep AI Expertise is Shaping Healthcare | Arkangel AI x Oxer

Laura Velasquez of Arkangel AI hosts Dr. Luis Eduardo Pino, CEO of Oxer, for an evidence-driven discussion on deploying artificial intelligence in health, practical barriers to AI adoption, and effective enterprise models in the sector.

Summary

Laura Velasquez (Arkangel AI) interviews Dr. Luis Eduardo Pino (Oxer) to unpack how artificial intelligence in health is being implemented in Latin America. The conversation explores the journey from military medicine to AI entrepreneurship, revealing urgent gaps—and actionable solutions—in clinician adoption and system integration.

Episode at a Glance

  • Guests: Dr. Luis Eduardo Pino — CEO, Oxer
  • Topics: AI adoption in Latin American health, medical entrepreneurship, model validation, clinical decision support, education gaps, system integration
  • Why it matters for artificial intelligence in health: Implementation relies on bridging deep expertise with real patient impact, ensuring clinical validation and practical deployment, particularly in under-resourced settings.

Overview

Artificial intelligence in health is transforming clinical practices and healthcare businesses across Latin America. In this special episode, Laura Velasquez of Arkangel AI welcomes Dr. Luis Eduardo Pino, a physician-entrepreneur whose career spans the Colombian military, oncology, and leadership at Oxer. They detail how the region lags in tech adoption yet presents significant opportunities for innovation.

From deploying early rule-based expert systems in combat settings to building scalable generative models at Oxer, Dr. Pino shares unique lessons about mindset shifts, technical challenges, and the crucial role of multidisciplinary collaboration. Real-world initiatives and failures ground this episode, offering practical advice to drive change in artificial intelligence in health.

Key Takeaways

  • AI models must be clinically validated with real patients and providers before full deployment.
  • Education gaps among clinicians are a major barrier to adopting AI tools in health.
  • Multidisciplinary teams—combining medical, analytical, and technical expertise—accelerate effective solutions.
  • Digital integration in domains like oncology requires deep sector knowledge, not just technical prowess.

Chapter Markers

  • [00:00] The big promise: Can AI truly transform care?
  • [05:12] Dr. Pino’s path from military medicine to Oxer and AI entrepreneurship
  • [14:37] From prototypes to deployment: Lessons from Maya Health and Oxer
  • [22:09] Obstacles and accelerators for real-world AI adoption in Latin American health systems

Notable Ideas

  • “Artificial intelligence is a tool that lets us be less intuitive—and hopefully more human.” — Dr. Luis Eduardo Pino, Oxer
  • “Before building AI solutions, you must deeply know the health sector—otherwise, the solutions risk being superficial.” — Dr. Luis Eduardo Pino, Oxer

Why This Matters

For clinicians, the integration of artificial intelligence in health can shift decision-making from intuition to evidence, reducing inefficiencies and bringing measurable improvements to patient care. The episode highlights, via Oxer’s work, how clinical validation is vital if AI models are to achieve impact beyond academic prototypes.

For health system leaders and medical-affairs professionals, multidisciplinary collaboration and sector-specific expertise—combining companies like Arkangel AI and Oxer—are essential to bridge technology with the realities of practice. This ensures that investments in AI lead to outcomes that clinicians and patients can trust, especially in resource-constrained settings.

About Arkangel AI

Arkangel AI empowers healthcare professionals and systems in Latin America to harness artificial intelligence in health. The organization specializes in solutions that translate cutting-edge AI research into tools for clinicians, administrators, and researchers—facilitating scalable, ethical, and impactful digital transformation. Learn more at arkangel.ai or see AI ethics principles at the Google AI Responsible AI site.

FAQ

  • Q: How can clinicians start adopting artificial intelligence tools in health safely?

    A: Both Arkangel AI and Oxer recommend starting with clinically validated tools and involving multidisciplinary teams—including data scientists and domain experts—in selection and deployment. Continuous education and awareness are key to safe adoption.

  • Q: What are the main barriers to using artificial intelligence in health in Latin America?

    A: Dr. Pino highlights a broad education gap among clinicians, lack of clinical validation, and insufficient integration between technical teams and healthcare providers. Strategic partnerships with organizations like Arkangel AI and Oxer help bridge these obstacles.